Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No substantive changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:08:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:33:18.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Page now shows that results have been submitted and are available. - Revision updated from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:26.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.1%
    Check dated 2025-09-14T19:14:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T15:34:30.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Nivolumab and additional resources related to Carcinosarcoma, while removing previous references to Cabozantinib and various location details.
    Difference
    6%
    Check dated 2025-08-31T11:53:32.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.